Latest Breaking News On - Kishorer iyer - Page 1 : comparemela.com

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesLin changRegion flamandeNew yorkJulie khlevnerChristopherv almarioKishorer iyerGerard greigLos angelesAstrid verbiestCenter trialUniversity of leuvenCedars sinai medical centerExchange commissionDrug administrationTranslational research center

Once-weekly administration of apraglutide reduces dependency on parenteral support in short bowel syndrome: Phase 3 trial

USA: Findings from phase 3 STARS trial demonstrate the potential for apraglutide to improve the standard of care for all adult patients with short bowel syndrome with intestinal failure (SBS-IF).

New yorkUnited statesKishorer iyerMichael shetzlineIronwood pharmaceuticalsPediatric intestine rehabilitationMount sinai hospitalCoordinating principal investigatorShort bowel syndrome

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMichael shetzlineBeth calitriGreg martiniMatt roacheKishorer iyerIronwood pharmaceuticals incIronwood pharmaceuticals nasdaqIronwood pharmaceuticalsExchange commissionPediatric intestine rehabilitationMount sinai hospitalCoordinating principal investigatorShort bowel syndromeAcute graft versus host disease

Ironwood Pharma: Apraglutide Trial Meets Primary Goal, But Some Secondary Goals Not Met; Stock Dips

(RTTNews) - Ironwood Pharmaceuticals, Inc. (IRWD), a GI-focused healthcare company, announced Thursday positive topline results from its Apragluti.

Kishorer iyerIronwood pharmaceuticals incMore such health newsApraglutide phaseCoordinating principal investigator

Ironwood Pharma (IRWD) Reports Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide

Ironwood Pharma (IRWD) Reports Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesKishorer iyerIronwood pharmaceuticals incIronwood pharmaceuticalsPediatric intestine rehabilitationMount sinai hospitalCoordinating principal investigator